Abbott Scores a 'Long-Awaited Win' in Diabetes

The diabetes management space just got a whole lot more interesting.

FDA has cleared Abbott's FreeStyle Libre 2 and FreeStyle Libre 3 integrated continuous monitoring sensors for integration with automated insulin delivery (AID) systems.